TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein

Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway

(2016) Xuan Su et al.   Oncotarget

Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A

(2015) Chen Yang et al.   Cellular & Molecular Immunology

TRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7

(2015) Yanming Wang et al.   FEBS LETTERS

Enhanced expression of trim14 gene suppressed Sindbis virus reproduction and modulated the transcription of a large number of genes of innate immunity

(2015) V. V. Nenasheva et al.   IMMUNOLOGIC RESEARCH

Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A

(2015) Marie-Sophie Hiet et al.   JOURNAL OF HEPATOLOGY

Transmitted/Founder Hepatitis C Viruses Induce Cell-Type- and Genotype-Specific Differences in Innate Signaling within the Liver

(2015) Angela M. Mitchell et al.   mBio

USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms

(2015) Zhifen Yang et al.   Scientific Reports

Lentiviral Effector Pathways of TRIM Proteins

(2014) Filippo Turrini et al.   DNA AND CELL BIOLOGY

TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination

(2014) J. Yan et al.   Journal of Molecular Cell Biology

Interferon-Inducible Cholesterol-25-Hydroxylase Inhibits Hepatitis C Virus Replication via Distinct Mechanisms

(2014) Yongzhi Chen et al.   Scientific Reports

Approaches to hepatitis C treatment and cure using NS5A inhibitors

(2014) Raymond Schinazi et al.   Infection and Drug Resistance

Emerging concepts in immunity to hepatitis C virus infection

(2013) Hugo R. Rosen   JOURNAL OF CLINICAL INVESTIGATION

TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation

(2013) A. Di Pietro et al.   JOURNAL OF VIROLOGY

The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection

(2013) Ralf Bartenschlager et al.   NATURE REVIEWS MICROBIOLOGY

Identification and Characterization of Multiple TRIM Proteins That Inhibit Hepatitis B Virus Transcription

(2013) Shijian Zhang et al.   PLoS One

TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-I-like receptor-mediated innate immune response

(2013) Z. Zhou et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication

(2012) Philippe Metz et al.   HEPATOLOGY

Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

(2012) Khayriyyah Mohd Hanafiah et al.   HEPATOLOGY

Correlation between NS5A Dimerization and Hepatitis C Virus Replication

(2012) Precious J. Lim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Subtype Specific Differences in NS5A Domain II Reveals Involvement of Proline at Position 310 in Cyclosporine Susceptibility of Hepatitis C Virus

(2012) Israr-ul Ansari et al.   Viruses-Basel

Exploitation of Lipid Components by Viral and Host Proteins for Hepatitis C Virus Infection

(2012) Kohji Moriishi et al.   Frontiers in Microbiology

TRIM79α, an Interferon-Stimulated Gene Product, Restricts Tick-Borne Encephalitis Virus Replication by Degrading the Viral RNA Polymerase

(2011) R. Travis Taylor et al.   Cell Host & Microbe

TRIM22 Inhibits HIV-1 Transcription Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF- B-Responsive Long Terminal Repeat Elements

(2011) A. Kajaste-Rudnitski et al.   JOURNAL OF VIROLOGY

A diverse range of gene products are effectors of the type I interferon antiviral response

(2011) John W. Schoggins et al.   NATURE

Pattern Recognition Receptors and Inflammation

(2010) Osamu Takeuchi et al.   CELL

New developments in the induction and antiviral effectors of type I interferon

(2010) Su-Yang Liu et al.   CURRENT OPINION IN IMMUNOLOGY

Hepatitis C Virus Nonstructural Protein 5A: Biochemical Characterization of a Novel Structural Class of RNA-Binding Proteins

(2010) J. Hwang et al.   JOURNAL OF VIROLOGY

An unsuspected drug target

(2010) Catherine L. Murray et al.   NATURE

Assembly of infectious hepatitis C virus particles

(2010) Ralf Bartenschlager et al.   TRENDS IN MICROBIOLOGY

Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain

(2009) Bo Gao et al.   HEPATOLOGY

TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus

(2009) P. Eldin et al.   JOURNAL OF GENERAL VIROLOGY

The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope

(2008) J-L Perfettini et al.   CELL DEATH AND DIFFERENTIATION

TRIM E3 Ligases Interfere with Early and Late Stages of the Retroviral Life Cycle

(2008) Pradeep D. Uchil et al.   PLoS Pathogens

The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22

(2008) Stephen D. Barr et al.   PLoS Pathogens